ATE329264T1 - Nachweis von produkten von apoptosis - Google Patents
Nachweis von produkten von apoptosisInfo
- Publication number
- ATE329264T1 ATE329264T1 AT99910360T AT99910360T ATE329264T1 AT E329264 T1 ATE329264 T1 AT E329264T1 AT 99910360 T AT99910360 T AT 99910360T AT 99910360 T AT99910360 T AT 99910360T AT E329264 T1 ATE329264 T1 AT E329264T1
- Authority
- AT
- Austria
- Prior art keywords
- therapy
- patients
- effectiveness
- tumour
- present
- Prior art date
Links
- 230000006907 apoptotic process Effects 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 5
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 230000001640 apoptogenic effect Effects 0.000 abstract 2
- 206010021113 Hypothermia Diseases 0.000 abstract 1
- 108010047956 Nucleosomes Proteins 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 230000002596 correlated effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002631 hypothermal effect Effects 0.000 abstract 1
- 230000000302 ischemic effect Effects 0.000 abstract 1
- 210000001623 nucleosome Anatomy 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Physiology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Holo Graphy (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19811739A DE19811739A1 (de) | 1998-03-18 | 1998-03-18 | Verlaufskontrolle der Radio- oder Chemotherapie bei Tumorpatienten durch die Detektion apaptotischer Produkte |
| US7949498P | 1998-03-26 | 1998-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE329264T1 true ATE329264T1 (de) | 2006-06-15 |
Family
ID=26044710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99910360T ATE329264T1 (de) | 1998-03-18 | 1999-03-18 | Nachweis von produkten von apoptosis |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7759071B2 (de) |
| EP (1) | EP1064549B1 (de) |
| JP (1) | JP3517642B2 (de) |
| AT (1) | ATE329264T1 (de) |
| AU (1) | AU2934299A (de) |
| ES (1) | ES2265682T3 (de) |
| WO (1) | WO1999047924A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4276843B2 (ja) * | 2001-03-23 | 2009-06-10 | 芳之 金井 | モノヌクレオソーム及びその製造方法、ヌクレオソームに特異的な抗体の測定方法、自己免疫病診断方法、ヌクレオソームｄｎａ製造方法、ｄｎａプレート、ｄｎａプレート製造方法、並びに抗ｄｎａ抗体測定法 |
| WO2003070894A2 (en) * | 2002-02-20 | 2003-08-28 | University Of Virginia Patent Foundation | A non-invasive diagnostic test utilizing histone modification markers |
| GB0319376D0 (en) | 2003-08-18 | 2003-09-17 | Chroma Therapeutics Ltd | Histone modification detection |
| GB201012662D0 (en) | 2010-07-28 | 2010-09-15 | Valirx Plc | Method for detecting the presence of a gynaecological growth |
| GB201115095D0 (en) * | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
| GB201115099D0 (en) | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes |
| JP6263474B2 (ja) * | 2011-12-07 | 2018-01-17 | シンガポール ボリション ピーティーイー リミテッド | ヌクレオソームアダクト検出法 |
| EP2775304A1 (de) * | 2013-03-07 | 2014-09-10 | Universitätsspital Basel | Verfahren zum Nachweis einer entzündlichen Störung |
| CN110669826B (zh) | 2013-04-30 | 2025-01-07 | 加州理工学院 | 通过顺序杂交编条形码的分子多重标记 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5500432A (en) | 1990-08-01 | 1996-03-19 | The Scripps Research Institute | Induction and inhibition of apoptosis |
| JP3190042B2 (ja) * | 1991-10-31 | 2001-07-16 | マトリテク インコーポレイテッド | 核マトリックス蛋白液アッセー |
| DE4318402A1 (de) * | 1993-06-03 | 1994-12-08 | Boehringer Mannheim Gmbh | Verfahren zum Nachweis eines programmierten oder induzierten Zelltods eukaryontischer Zeller |
| DE4319506A1 (de) * | 1993-06-12 | 1994-12-15 | Boehringer Mannheim Gmbh | Verfahren zum Nachweis metabolisch markierter DNA |
| US5750360A (en) * | 1995-06-07 | 1998-05-12 | Lxr Biotechnology Inc. | Method for quantitatively measuring apoptosis |
| JP3392626B2 (ja) * | 1996-02-21 | 2003-03-31 | カネボウ株式会社 | 育毛剤の評価方法 |
| ES2347854T5 (es) * | 1996-03-26 | 2014-07-24 | Michael S. Kopreski | Método que permite el uso de RNA extracelular extraído de plasma o suero para detectar, monitorizar o evaluar un cáncer |
| WO1998034118A1 (en) * | 1997-01-30 | 1998-08-06 | Yale University | Diagnostic methods and compositions based on the distribution of rad51 |
| JP3688436B2 (ja) * | 1997-07-08 | 2005-08-31 | 株式会社カネボウ化粧品 | 育毛剤の評価方法 |
| US7229772B1 (en) * | 1998-03-18 | 2007-06-12 | Roche Diagnostics Gmbh | Detection of apoptotic products |
-
1999
- 1999-03-18 AT AT99910360T patent/ATE329264T1/de active
- 1999-03-18 ES ES99910360T patent/ES2265682T3/es not_active Expired - Lifetime
- 1999-03-18 WO PCT/EP1999/001798 patent/WO1999047924A1/en not_active Ceased
- 1999-03-18 EP EP99910360A patent/EP1064549B1/de not_active Expired - Lifetime
- 1999-03-18 AU AU29342/99A patent/AU2934299A/en not_active Abandoned
- 1999-03-18 JP JP2000537068A patent/JP3517642B2/ja not_active Expired - Lifetime
-
2007
- 2007-04-23 US US11/738,899 patent/US7759071B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999047924A1 (en) | 1999-09-23 |
| US7759071B2 (en) | 2010-07-20 |
| EP1064549A1 (de) | 2001-01-03 |
| US20080108094A1 (en) | 2008-05-08 |
| ES2265682T3 (es) | 2007-02-16 |
| AU2934299A (en) | 1999-10-11 |
| JP2002507722A (ja) | 2002-03-12 |
| EP1064549B1 (de) | 2006-06-07 |
| JP3517642B2 (ja) | 2004-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60137264D1 (de) | Monoklonale antikörper und zelloberflächenantigene zum nachweis und zur behandlung von kleinzelligem lungenkrebs (sclc) | |
| PH12022550578A1 (en) | Method for identifying responders to smarca2/4 degraders | |
| ATE442592T1 (de) | Detektion und/oder beobachtung von synuclein- assoziierten krankheiten | |
| ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| BRPI0213786B8 (pt) | peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
| TR199801390T2 (xx) | Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler | |
| ATE495791T1 (de) | System zur überwachung oder behandlung von erkrankungen des nervensystems | |
| PH12015501744B1 (en) | Therapeutic and diagnostic target for cancer comprising dll3 binding reagents | |
| WO2002059604A3 (en) | Diagnosis and treatment of multiple sclerosis | |
| BR0209646A (pt) | genes expressos em cáncer de mama como alvos de prognósticos e terapêuticos | |
| ATE411016T1 (de) | Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten | |
| ES2153665T3 (es) | Usos terapeuticos de productos proteicos bactericidas/incrementadores de la permeabilidad (bpi) para la meningococemia humana. | |
| ATE411018T1 (de) | Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en) | |
| ATE320006T1 (de) | Methode zum nachweis von zell-apoptose | |
| CY1110503T1 (el) | Πενταμιδινη για θεραπεια καρκινου | |
| ATE292801T1 (de) | Verfahren zum screening von inhibitoren von asp2 | |
| AU2934299A (en) | Detection of apoptotic products | |
| ATE356994T1 (de) | Screeningverfahren mit pim1-kinase oder pim3- kinase | |
| HUP9903299A2 (hu) | FAS-antigén elleni antitestek | |
| DE60309887D1 (de) | Kombination von einem aromatasehemmer mit einem bisphosphonat | |
| DE60044350D1 (de) | Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs | |
| ATE283703T1 (de) | Neurodegenerative-erkrankung verwandtes gen | |
| ATE283478T1 (de) | Verfahren und vorrichtung zur bestimmung des transformationspotentials von verbindungen. | |
| ES530592A0 (es) | Procedimiento para la inactivacion de sustancias que provocan reacciones de incompatibilidad en productos sanguineos | |
| DE69910425D1 (de) | Neue therapeutische verwendung von nicergoline |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1064549 Country of ref document: EP |